Inve India ▾

The Bombay Burmah Trading Corporation share price & results

The Bombay Burmah Trading Corporation Limited· Fast Moving Consumer Goods

Results to
Jun 2026
Latest analysed call
Q1 FY24
Ownership as of
Sept 2026

Runs tea estates, auto-electric components and dental care, and holds Britannia Industries as a subsidiary.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue67.5 ₹ crore−5.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin-3.5 %+0.8 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit7.9 ₹ crore−76.4% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity19.57 %−3.2 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin11.71 %+0.9 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)6.63 %−0.2 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

1 of 3 judged targets kept · 2 open · verdicts reflect calls analysed to Q1 FY24.

The Bombay Burmah Trading Corporation Limited management guidance track record on Inve: 5 targets tracked across analysed earnings calls (1 achieved, 2 missed, 2 open).

TargetOriginal wordingSaidLatest callVerdict
Healthcare Division Growth8% to 9% growth for FY23
Call transcript, Q1 FY23 · 25 Aug 2022
Q1 FY23Q1 FY24:Reconfirmed at the FY23 AGM: turnover ₹29.17 cr vs ₹19.41 cr, +50.28%. The prior-year base differs from the ₹18.62 cr stored earlier, but the 8-9% target is far exceeded on either base.
Call transcript, Q1 FY24 · 30 Sept 2023
Achieved
Tea Plantation PerformanceConsiderable improvement in the next 6 to 9 months
Call transcript, Q4 FY20 · 24 Jul 2020
Q4 FY20Q1 FY24:Still not addressed as a commitment. The latest data shows no sign of sustained improvement: FY23 tea production fell to 37.38 lakh kg from 41.72 lakh kg (-4.34) on excess rain at Mudis, and tea revenue fell ₹4 cr despite higher prices.
Call transcript, Q1 FY24 · 30 Sept 2023
Ghosted
NCD IssuanceIssue NCDs up to ₹300 crore in FY23
Call transcript, Q1 FY23 · 25 Aug 2022
Q1 FY23Q1 FY24:Item nine at the AGM again sought approval for redeemable NCDs up to ₹300 crore, now for FY24. No issuance was reported and no new timeline was given. The resolution is an enabling approval, so the commitment is rolled over rather than fulfilled.
Call transcript, Q1 FY24 · 30 Sept 2023
Delayed

Source: Inve Guidance Tracker for The Bombay Burmah Trading Corporation Limited · to Q1 FY24

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

2 of The Bombay Burmah Trading Corporation Limited's 5 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 2 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹1,177 +1.75% · +₹20.2

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −43.4% 1Y

₹1.2k₹1.4k₹1.6k₹1.8k₹2.0kOct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26

1Y: ₹2,078.9 on 24 Oct 2025 → ₹1,177. High ₹2,078.9 (24 Oct 2025), low ₹1,128.6 (23 Oct 2026).

Previous close
₹1,156.8
Market cap
₹8.1k Cr
52-week range
₹1,128.6 – ₹2,035.1
One year
−42.17%
Price to earnings (TTM to Jun 2026)
6.51×
Return on equity (TTM to Jun 2026)
19.57%

Overview

Symbol
NSE:BBTC
Exchange
NSE
Currency
INR

What The Bombay Burmah Trading Corporation Limited does

Based on the company's own presentations, annual report and earnings calls.

The Bombay Burmah Trading Corporation is a Wadia Group company that both operates businesses directly and holds a controlling stake in Britannia Industries, its material listed subsidiary. Its own operations span tea plantations in Tamil Nadu and Tanzania, manufacture of auto electric components (Electromags) sold to the automotive industry, and a Health Care Division making dental products at Rudrapur, Uttarakhand. The corporation earns through sale of tea, auto components and dental products, dividend income from Britannia and other group investments, and has been progressively exiting non-core assets such as its coffee business and Tanzania tea estates.

Segments

  • Plantation - Tea
  • Auto Electric Components (Electromags)
  • Health Care Division
  • Investment in Britannia Industries
Material listed subsidiary
Britannia Industries Limited
Tea estates
Mudis Group, Dunsandle and Singampatti (Tamil Nadu); Usambara Group and Marvera (Tanzania)
Auto electric components manufacturing units
3 (Kottivakkam, Chennai, Tamil Nadu)
Health Care (dental) manufacturing facility
Rudrapur, Uttarakhand
Overseas branch
Malaysia branch office (Johor Bahru)
Material overseas subsidiaries
Leila Lands Senderian Berhad, Leila Lands Limited, ABI Holdings Limited
Founded 1863Headquarters Mumbai, Maharashtra, India Company website

Your own record

Start an Inve Case for The Bombay Burmah Trading Corporation Limited

Free account: one company. Everything above stays public.

Write why you follow The Bombay Burmah Trading Corporation Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds